miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1

S Santasusagna1, I Moreno2, A Navarro1

  • 1Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain.

Abstract

Insights

MicroRNA-328 directly targets SLC2A1/GLUT1, a key player in colon cancer metabolism. This microRNA is downregulated in colon tumors, suggesting its role in the Warburg effect.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Altered cellular metabolism is a hallmark of colon cancer.
  • The role of microRNAs in regulating cancer metabolism requires further investigation.
  • SLC2A1 (Solute Carrier Family 1, Member 1), also known as GLUT1, is implicated in cancer metabolism.

Purpose of the Study:

  • To investigate whether microRNA-328 (miR-328) directly regulates SLC2A1/GLUT1 expression in colon cancer cells.
  • To explore the role of miR-328 in colon cancer metabolism.
  • To determine the expression levels of miR-328 in colon tumor tissues.

Main Methods:

  • In silico bioinformatic analyses to identify miR-328 targets and pathways.
  • Luciferase reporter assays and Western blot analyses in LOVO and SW480 colon cancer cell lines.
  • Assessment of miR-328 expression in 47 paired colon tumor and normal tissue specimens.

Main Results:

  • Luciferase assays confirmed direct targeting of the SLC2A1 3'-untranslated region (UTR) by miR-328, leading to decreased luciferase activity.
  • Western blot analysis validated the regulatory effect of miR-328 on SLC2A1/GLUT1 expression.
  • miR-328 expression was significantly downregulated in colon tumor tissues compared to adjacent normal tissues.

Conclusions:

  • miR-328 directly targets and regulates SLC2A1/GLUT1 expression in colon cancer.
  • Downregulation of miR-328 in colon cancer may contribute to the Warburg effect.
  • miR-328 represents a potential biomarker and therapeutic target in colon cancer, inversely correlating with SLC2A1/GLUT1 upregulation.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
The Colonization of Land02:22

The Colonization of Land

Changes in the environment of the early Earth drove the evolution of organisms. As prokaryotic organisms in the oceans began to photosynthesize, they produced oxygen. Eventually, oxygen saturated the oceans and entered the air, resulting in an increase in atmospheric oxygen concentration, known as the oxygen revolution approximately 2.3 billion years ago. Therefore, organisms that could use oxygen for cellular respiration had an advantage. More than 1.5 years ago, eukaryotic cells and...
37.9K
What is Metabolism?00:52

What is Metabolism?

Overview
132.7K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
111.6K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
84.4K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K